T ransfusion-transmissible infections (TTIs), in particular those caused by human immunodeficiency virus Type 1 (HIV-1), remain a major concern for the safety of the blood supply. Prevention of transfusion-transmitted HIV-1 infection necessitates laboratory testing of all donations. In addition, many countries have implemented indirect strategies, including risk behavior-based donor selection and donor education programs. [1] [2] [3] [4] The prevalence of TTIs in donors is lower than that in the general population, demonstrating the effectiveness of selection procedures and the willingness of donors with risk behavior to self-defer. 5, 6 However, not all donors may disclose risk behavior, out of fear of judgment or because of test-seeking behavior, discontent with exclusion criteria, or the underestimation of own risk behavior and the genuine perception that one's blood is safe. [7] [8] [9] When confronted with a positive test result, 30% to 50% of HIVinfected donors in western countries report risk factors, including male-to-male sex (28%-47%) and injecting drug use (IDU; 0%-3%), which if revealed before donation would have led to permanent donor deferral. 5, 6, 10, 11 In most western countries, sex between men and women (SBMW) is the predominant self-reported route of transmission (38%-63%) among HIV-positive donors; the remainder reports minor blood-related risk factors (2%-10%) or no risk behavior at all (5%-22%). 5, 6, 10 Phylogenetic analysis can be used to study population-based transmission patterns of fast-evolving pathogens like HIV-1.
12, 13 The highest HIV-1 viral diversity is observed in West and Central Africa, while in most western countries the HIV-1 epidemic is largely driven by HIV-1 Subtype B. 14, 15 Earlier phylogenetic studies from the Netherlands, Flanders, Switzerland, and the United Kingdom have revealed the presence of HIV-1 transmission clusters specifically linked to men who have sex with men (MSM), SBMW, or IDU and suggest the coexistence of separated HIV-1 epidemics with limited overlap between different risk groups. [16] [17] [18] [19] This study aims to improve our understanding of the underlying risk factors of HIV-1 infections in Dutch and Flemish donors by shifting the scope from the donor to the infecting viral strain. A large phylogenetic study was performed, including more than 10,000 HIV-1 sequences obtained from donors, registered HIV-1 patients in the Netherlands and Flanders, and international public databases, to determine the most plausible mode of HIV transmission for Dutch and Flemish donors.
MATERIALS AND METHODS

Study population: Dutch and Flemish donors
Participants include all first-time and repeat blood donors in the Netherlands and Flanders with confirmed positive HIV test results in the period 2005 to 2014. At each visit, donors completed a standardized donor health questionnaire, a donor physician or assistant performed a health check, and blood was tested for TTIs. Donors who reported risk factors strongly associated with an increased risk for HIV infection, including male-to-male sex, commercial sex work, and IDU, were permanently deferred and not tested for TTIs. If tested HIV infected, donors were invited to return to the blood bank for medical counseling and for repeat testing to exclude mistaken donor identities and laboratory errors. A trained medical counselor conducted a face-to-face interview using a standardized posttest risk questionnaire dealing with potential risk factors for blood-borne and sexually transmitted infections to identify the most likely route of HIV infection.
Study population: reference databases
ATHENA cohort: HIV-infected patients in the Netherlands
The ATHENA national observational HIV cohort encompasses all HIV-infected patients followed longitudinally in the 26 HIV treatment centers in the Netherlands since 1996, except for the 2% of patients who opt out. 16 Demographic data are collected at cohort entry, including age, sex, country of birth, and the most likely route of transmission. At each follow-up visit, clinical, virologic, and immunologic data are collected, as well as data on the use of combination antiretroviral therapy. HIV-1 polymerase (pol) sequences are obtained as part of the screening for resistance to antiretroviral drugs, before and during treatment with combination antiretroviral therapy. For this study we included all ATHENA participants who had been enrolled before November 2015 and had a HIV-1 pol sequence available with a minimum length of 750 nucleotides (n 5 9106). This includes 38% of all 23,861 Dutch HIV-1 patients in care since 1996.
Leuven cohort: HIV-infected patients in Flanders
The Leuven cohort includes all patients for whom the diagnosis of HIV infection has been confirmed at the 
Routine HIV donor screening and confirmatory testing
Routine HIV donor screening in the Netherlands and Flanders is very similar and has been described previously. 4 HIV-infected donors were predominantly male (69%) and had a median age of 45 years, and 95% were born in the Netherlands or Belgium (Table 1 ). Compared to HIV-infected patients, donors were older at HIV diagnosis (45 years vs. 36 years; p 5 0.01) and more likely to be born in the Netherlands or Belgium (95% vs. 56%; p < 0.001). None of the HIV-infected donors was from sub-Saharan Africa, while migrants from sub-Saharan Africa accounted for 15 and 22% of HIV-infected patients in the Netherlands and Flanders, respectively. During posttest counseling, 69% of HIV-infected donors reported potential risk factors: male-to-male sex (24%), SBMW (36%), or bloodrelated risk factors (9%). None of the donors reported IDU. The remaining HIV-infected donors reported no risk behavior (18%) or did not return for posttest counseling (13%). Risk profiles among HIV-infected donors and patients were different. Dutch donors reported less maleto-male sex (23% vs. 61%, p < 0.001) and more minor blood-related risk factors (13% vs. 2%; p < 0.01) or no risk factors (23% vs. 5%; p < 0.001) compared to Dutch HIVinfected patients. In Flanders, the absence of self-reported risk behavior (42% vs. 24%; p 5 0.05) was higher in donors than in patients.
For HIV-infected repeat donors, the median interval between the last HIV-negative and the first HIV-positive donation was 119 days (interquartile range [IQR] , 58-366 days); five of 40 (13%) repeat donors had an HIV-negative test result within 30 days before HIV diagnosis, suggestive of very recent HIV infection. Pol sequences were obtained for 24 of 31 (77%) Dutch and 23 of 24 (92%) Flemish HIVinfected donors. Six male and two female donors with HIV had no serum available for testing: two donors reported male-to-male sex, two donors reported SBMW as the most likely source of HIV infection, and four donors did not return for posttest counseling. Subtype B was the predominant subtype among HIV-infected donors in the Netherlands (67%) and Flanders (70%). The other 15 donors had infections with circulating recombinant form CRF02_AG (13%), Subtype C (6.3%), Subtype A1 (6.3%), Subtype F1 (2.1%), CRF09_cpx (2.1%), and an unclassified D/A1 recombinant (2.1%; Table 1 ). Among donors, we found a significant increase of non-B subtypes over time from Figure 1 shows the phylogenetic tree of 469 HIV-1 sequences colored according to the self-reported HIV risk factor of the host, including 47 donor sequences, 279 Dutch ATHENA sequences, 57 Flemish Leuven cohort sequences, and 88 foreign GenBank sequences. The demographic data of Dutch and Flemish HIV-1-infected patients with 
Phylogenetic analysis
3 (13) 3 (13) 661 (7) 115 (10) Other recombinants 1 (4) 1 (4) 189 (2) 21 (2) *Different (p < 0.05) between HIV-1-infected Dutch donors and patients. † Different (p < 0.05) between HIV-1-infected Flemish donors and patients.
(almost) identical HIV-1 sequences were compared to avoid duplicates of patients who moved from the Netherlands to Flanders or vice versa. Figure S1 (available as supporting information in the online version of this paper) shows the same phylogenetic tree colored according to the country of sampling to place sequences or clusters in either a national or an international context. Of the 47 donor sequences, 35 (74%) donors robustly clustered with two or more reference strains, six (13%) donors robustly clustered with only one reference sequence, and six (13%) donors were not part of robust HIV clusters (singletons). Donor characteristics, cluster characteristics, and the allocated most likely risk factor for HIV infection are reported in Table 2 (Netherlands) and Table 3 (Flanders). All six HIV-infected Dutch donors who reported male-to-male sex during posttest counseling were infected with HIV-1 Subtype B and were part of robust Dutch MSM clusters ( Fig. 1: N01 to N06 ). The six Dutch male donors with HIV-1 Subtype B infection who reported non-MSM risk factors abroad (N08 to N10) or no risk factors (N07, N11, N13) were also part of robust Dutch MSM clusters. Two Dutch male donors with HIV-1 Subtype non-B infection reported possible nosocomial transmission within the Netherlands: one donor was part of a robust Dutch MSM cluster (N12, CRF02_AG) and one donor was part of a European SBMW cluster (N14, Subtype C, country of sampling; see Fig. S1 ). Overall, in 13 of 14 (93%) male HIV-infected Dutch donors there was evidence for maleto-male sexual transmission. In contrast, only one of the 10 HIV-infected female donors (N24) was part of a robust MSM cluster, and she indeed reported a bisexual partner. Six female donors reported a male sexual partner from sub-Saharan Africa, all six donors were infected with HIV non-B subtypes and interspersed with HIV-1 sequences Table 2 ), suggesting that these donors also participated in ATHENA: Five donors reported corresponding risk behavior before and after being referred to clinical care (N04, N09, N12, N18, N23), and two donors who initially reported no (N07) or nosocomial risk factors (N08) during posttest donor counseling did report male-to-male sex at entry in ATHENA. All five HIV-infected Flemish donors who reported male-to-male sex during posttest counseling were infected with HIV Subtype B: four donors (F01 to F04) were part of robust MSM clusters, and one donor (F05) had a singleton sequence. The remaining nine Flemish male donors with HIV-1 Subtype B infection reported either SBMW or no risk factors: three donors were part of robust MSM clusters (F06, F08, F10), two donors clustered with only one MSM reference sequence (F07, F09), one donor robustly clustered with Flemish sequences linked to "unknown" risk factors (F12), and three donors had singleton sequences (F15, F16, F18) . None of the four Flemish male donors with HIV-1 non-B subtypes reported male-to-male sex: one donor (F11, Subtype F) was part of a robust MSM cluster, one donor was part of the SBMW branch of a mixed MSM/SBMW cluster (F13, Subtype A1), one donor was part of a Flemish SBMW cluster (F14, CRF02_AG), and one donor robustly clustered with Dutch and Flemish sequences linked to unknown risk factors (F17, CRF02_AG). Overall, in 11 of 18 (61%) male Flemish donors with HIV, we found phylogenetic evidence for male-to-male sexual transmission. None of the five female donors was part of an MSM cluster: one donor had a sexual partner from sub-Saharan Africa (F21; recombinant D/A1) and interspersed with African HIV-1 sequences, one donor was born in Russia (F22; Subtype A1) and interspersed with Russian HIV-1 sequences, one donor reported a new male partner (F23; CRF02_AG) and robustly clustered with a Flemish sequence linked to SBMW, and for two donors with unknown risk behavior additional phylogenetic analysis did not provide extra information on the potential source of infection (F19, F20; both Subtype B). Overall, two of 23 (9%) HIV-infected Flemish donors had (approximately) 100% sequence similarity with an HIV-patient of the same sex, age, and country of birth, suggesting that these donors also participated in the Leuven cohort: one donor (F17) reported corresponding risk behavior before and after being referred to clinical care, and one donor with initially no self-reported risk behavior (F06) reported male-to-male sex after being referred to clinical care.
In summary, the combined results of self-reported risk behavior and phylogenetic clustering identified maleto-male sex (75%), SBMW (13%), and unknown risk behavior (13%) as the most likely risk factor for HIV in male donors. SBMW was identified as the most likely risk factor in female donors (93%). Nine women (60%) most likely acquired their HIV infection from a foreign partner (predominantly from sub-Saharan Africa), and one woman most likely acquired HIV from a bisexual man. Risk behavior disclosed during posttest counseling was more likely to be concordant with phylogenetic clustering in female donors compared to male donors (93% vs. 41%, p 5 0.001). No differences in median age (47 years vs. 49 years, p > 0.05) and interdonation interval (88 days vs. 112 days, p > 0.05) were observed among male donors who reported male-to-male sex during the exit interview and male donors who were categorized as MSM based on phylogenetic analysis.
DISCUSSION
Using a molecular epidemiologic approach we showed that 75% of HIV-infected male donors in the Netherlands and Flanders are part of robust MSM-specific clusters, suggesting that male-to-male sex is the predominant mode of transmission in Dutch and Flemish male donors who test positive for HIV. Except for one HIV-infected female donor who indeed reported a bisexual partner, none of the female donors were part of MSM-specific clusters. Phylogenetic analysis confirms SBMW as the most likely route of transmission in 93% of HIV-infected female donors; 60% reported a foreign sexual partner predominantly from HIV-endemic countries in sub-Saharan Africa. This study underlines that, provided the availability of extensive national HIV sequence databases, HIV molecular typing is of additional value to traditional posttest counseling and provides insight in the underlying risk behavior of donors who report no or less plausible risk factors for the acquisition of HIV.
Recent phylodynamic reconstructions of the ongoing HIV epidemic in western Europe have confirmed the presence of both longstanding and recently evolved risk group-specific transmission networks for HIV Subtype B and HIV non-B subtypes. [16] [17] [18] [19] 24, 25 In most western coun- During the study period male-to-male sex was a permanent donor deferral criterion in both the Netherlands and Flanders. Male donors were explicitly asked for sexual contacts with other men before each donation and deregistered if reporting male-to-male sex. Nevertheless, phylogenetic analysis suggests that the vast majority of HIV infections among male donors was acquired through male-to-male sex. Improving compliance regarding the disclosure of male-to-male sex would efficiently lower the number of HIV-infected donors in the Netherlands and Flanders. Although the motivators for noncompliance are numerous, computer-assisted structured interviewing could stimulate self-deferral of donors at risk for TTIs by creating a safe and more private environment in which eliciting sensitive information might be more easy. 35 In total, 11 of 24 (46%) of the male donors who were part of robust MSM clusters said they were MSM during posttest counseling, an additional three donors (13%) reported male-to-male sex after being referred to clinical care (based on matching sequences plus demographics in HIV-patient cohorts), and 10 donors (42%) were characterized as MSM solely based on the predominant risk factor for the cluster to which their HIV strain belonged. Lifetime donor deferral of MSM was introduced as a response to the AIDS epidemic in the 1980s. 36 Most western countries have been hesitant to revise this policy, since MSM remain disproportionally affected by HIV compared to men who only have sex with women. In the Netherlands and Flanders, MSM accounted for 67 and 32% of all newly diagnosed HIV infections in 2014. 37 The scientific justification of lifetime deferral for MSM, however, has weakened over time. 36 The HIV infectious window period has been reduced to approximately 10 days after the implementation of increasingly sensitive NATs. 38, 39 Public pressure to liberalize the MSM deferral policy has caused various countries, including the Netherlands per December 2015, to change from permanent to temporary donor deferral. In Flanders, the discussion on relaxing donor deferral criteria for MSM is still ongoing. Mathematical modeling suggested that with a 1-year deferral policy for MSM the number of newly diagnosed HIV infections among male donors could increase up to 35-fold, but recent surveys indicate unchanged high compliance and fortunately no sizeable increase in HIV rates after its implementation in the United Kingdom, Canada, and Australia. 40 Even with a sizeable increase of HIV infections, the risk of nonrecent HIV infections escaping routine donor screening is extremely low. If, on the other hand, less stringent donor deferral criteria induce noncompliance, the number of window donations and hence the number of infectious donations inadvertently becoming available for transfusion might increase. 39 To illustrate, 13% of HIV-positive repeat donors in our study had an HIV-negative test result within the 30 days before HIV diagnosis. With regard to sexual risk behavior, all seven HIV-positive Dutch donors who admitted to male-to-male sex during posttest counseling reported a new male sex partner in the previous 6 months, five of whom reported multiple anonymous sexual contacts and no or infrequent condom use. A more permissive donor deferral policy (e.g., sexual abstinence for 6 or 12 months or a monogamous steady relationship) would not have allowed these men to donate, if compliant. Unfortunately, no data on the motivators for noncompliance were obtained. Our study has several limitations. First, men infected with an MSM-specific HIV-1 strain could have acquired their infection through routes other than male-to-male sex, for example, via the use of unsterile equipment previously used for an HIV-infected MSM or via sex with a woman who previously had a bisexual partner. However, the fact that only male donors and none of the female donors (except one female donor who indeed reported a bisexual partner) were part of robust MSM-specific clusters is highly suggestive that our phylogeny correctly reflects actual transmission networks. Second, the HIV reference databases included only 38 and 15% of the diagnosed HIV-infected population in the Netherlands and Flanders, respectively. ATHENA is a national database, but the Flemish database comprises mainly HIV-infected patients from the region of Flemish Brabant, whereas only 17% of HIV-infected Flemish donors were from Flemish Brabant. The limited number of reference sequences from the other five Flemish regions might have led to a relatively high number of singleton donor sequences and an underestimation of male-to-male sex as the most likely risk factor among HIV-infected male Flemish compared to Dutch donors (61% vs. 93%).
In conclusion, molecular HIV typing in combination with posttest counseling provides additional information on underlying risk factors for HIV infection among donors in low-endemic countries. Phylogenetic analysis suggests that HIV transmission routes in donors are not very different from those in the general population, predominantly being male-to-male sex for men and heterosexual transmission for women, in particular, with male partners from HIVendemic areas. As donor selection procedures elaborately address these HIV risk factors, this study further emphasizes the importance of an environment that encourages frank disclosure of sexual behavior and the need to educate donors on the risks of noncompliance for recipients. Clinical centers *Denotes site coordinating physician
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Additional Supporting Information may be found in the online version of this article. Table S1 . Positions in the HIV-1 reverse transcriptase and protease gene associated with major conferring resistance to nucleoside analogue reverse transcriptase inhibitors (NRTIs), nonnucleoside analogue reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs). Fig. S1 . Maximum likelihood phylogenetic tree including HIV-1 pol sequences (1074 nt) from Dutch and Flemish donors (n 5 47) plus for each donor the ten genetically most related HIV-1 reference sequences from ATHENA, UZ Leuven, Los Alamos HIV sequence database or Genbank. Branch color shows the country of sampling for reference and donor sequences.
